Codexis Inc (CDXS) - Utang marang Ekuitas

Lambang korporat lan logo Codexis, Inc. (CDXS)

Codexis, Inc. (CDXS) dominates the development of custom proteins for medicine and nutrition, leveraging its AI system and extensive patent portfolio. This price trend chart shows that the total debt-to-equity ratio is 2.36. The business relies on CodeEvolver to help partners optimize costs. A network of global carriers ensures supply stability, eliminating disruptions in the delivery of critical biocomponents.

CDXS: Total Utang marang Modal Codexis Inc 04.07.2022 - 27.10.2026
Sampel barang Codexis

The total debt-to-equity ratio measures the proportion of borrowed funds in the financing structure relative to the company's own resources. Low values for this metric indicate high financial autonomy and resilience to market shocks. By analyzing the total debt/equity chart, an investor can see the current leverage level, which for Codexis, Inc. (CDXS) is 2.36. This ratio confirms the company's balanced debt load, ensuring full coverage of operating expenses and investment costs through stable cash flows.

Analisis perusahaan pesaing

Total Utang marang Modal tempus.com (TEM)|Rasio Utang marang Ekuitas QGEN|Utang marang Ekuitas Ionis Pharma IONS|Rasio Utang marang Ekuitas Repligen Inc. (RGEN)|Total Utang marang Modal RNA (Avidity Biosciences)|Total Utang marang Modal crisprtx.com CRSP|WGS: Total Utang marang Modal|RARE: Rasio Total Utang marang Ekuitas|Utang marang Ekuitas BEAM|Sarepta Corp (SRPT) - Utang marang Modal|Total Utang marang Modal Twist Bioscience (TWST)|Rasio Utang marang Ekuitas 10xgenomics.com|Intellia Therapeutics, Inc. - Total Utang marang Modal|Utang marang Modal Stoke Therapeutics Inc STOK|BLFS - Rasio Total Utang marang Ekuitas|Rasio Utang marang Ekuitas Wave Pharma WVE|Total Utang marang Modal MAZE (Maze Therapeutics Inc)|SION: Koefisien Total Utang marang Modal|Prime Medicine - Utang marang Ekuitas|Koefisien Total Utang marang Modal Taysha Gene Therapies Inc|QURE - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi MeiraGTx Corp|RGNX (REGENXBIO Inc.) - Total Utang marang Modal|Koefisien Total Utang marang Modal SLDB (solidbio.com)|OCGN - Utang marang Ekuitas|Rasio Utang marang Ekuitas Pacific Biosciences of California, Inc. PACB|BNTC: Total Utang marang Modal|Design Corp (DSGN) - Rasio Total Utang marang Ekuitas|Rocket Pharmaceuticals - Rasio Total Utang marang Ekuitas|4dmoleculartherapeutics.com (FDMT) - Koefisien Total Utang marang Modal|Total Utang marang Modal LXEO|Rasio Total Utang marang Ekuitas Korro Bio, Inc|Total Utang marang Modal Editas EDIT|Rasio Utang marang Ekuitas Silence Therapeutics Corp SLN|PRQR - Rasio Total Utang marang Ekuitas|sangamo.com - Rasio Utang marang Ekuitas|Utang marang Ekuitas NAUT (Nautilus Biotechnology Inc)|MGX - Koefisien Total Utang marang Modal|Total Utang marang Modal Precision BioSciences, Inc.|GBIO (Generation Bio) - Rasio Utang marang Ekuitas|Utang marang Ekuitas Boundless Bio, Inc. (BOLD)|Rasio Utang marang Ekuitas Exicure Corp|Total Utang marang Modal IMNN|Total Utang marang Modal phiopharma.com (PHIO)|Mustang Bio - Total Utang marang Modal|TransCode Therapeutics Inc. - Rasio Total Utang marang Ekuitas|BNGO (Bionano) - Utang marang Ekuitas|APDN - Utang marang Modal|Total Utang marang Modal bluebird bio|ImmunoPrecise Antibodies Ltd. (IPA) - Rasio Utang marang Ekuitas|Total Utang marang Modal OMGA (Omega)|Utang marang Modal Singular Genomics Corp (OMIC)|Rasio Total Utang marang Ekuitas Regulus Therapeutics RGLS|Rasio Utang marang Ekuitas syros.com (SYRS)|Total Utang marang Modal TBIO|TRACON Pharmaceuticals Inc. - Koefisien Total Utang marang Modal|Utang marang Ekuitas UBX (Unity Bio)